-
Mashup Score: 0
Psychedelic drugs such as lysergic acid diethylamide (LSD) and psilocybin (‘magic mushrooms’) induce hallucinations and distort thought-processes. The intensity of a psychedelic ‘trip’ can cause distress, agitation, and even psychosis. A recent report showed that at least 8.4% of drug-related presentations to European emergency departments involve psychedelics.1 This proportion may increase as the clinical use of these agents expands.2 There are multiple ways to control a ‘bad trip’ and avoid hospitalisation. One is to take psychedelics under the supervision of a ‘trip-sitter’—a non-intoxicated friend who can provide psychological support. Another is to use additional psychoactive drugs—‘trip-killers’—to attenuate or prematurely end the psychedelic experience. Trip-killers are not new, but have received increased attention on social media in recent years.3 Information on trip-killers is not available through drug advice services, despite the probable risks they pose. To our knowledge,
Source: emj.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Quris-AI and Merck KGaA Come Together for AI-Enabled Drug Safety Tech | The Healthcare Technology Report. - 6 month(s) ago
Israeli pharmaceutical AI developer Quris-AI has announced a promising continuation of its partnership with the renowned scientific and technology firm Merck KGaA, Darmstadt, Germany. Building upon their successful initial collaboration, the companies conducted a preclinical investigation comparing Quris-AI’s cutting-edge medication toxicity prediction capabilities with traditional in vitro and in vivo methods. Merck plans to leverage Quris-AI’s expertise in assessing liver toxicity risks in potential
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Preserving Patient Access to Compounded Medications Act of 2017 - 7 month(s) ago
The act would have permitted health care facilities to stock up on compounded medications without forcing the supplying 503A pharmacies to register as outsourcing facilities.
Source: www.pharmacytimes.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Routine Hazardous Drug Wipe Tests Provide Springboard for Quality Improvement Initiatives - 10 month(s) ago
Routine surface wipe testing helps identify specific areas of hazardous drug contamination and guide nurse leaders towards establishing improved protocols.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Routine Hazardous Drug Wipe Tests Provide Springboard for Quality Improvement Initiatives - 10 month(s) ago
Routine surface wipe testing helps identifies specific areas of hazardous drug contamination and guide nurse leaders towards establishing improved protocols.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Routine Hazardous Drug Wipe Tests Provide Springboard for Quality Improvement Initiatives - 10 month(s) ago
Routine surface wipe testing helps identifies specific areas of hazardous drug contamination and guide nurse leaders towards establishing improved protocols.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
AnnMarie Walton, PhD, MPH, RN, OCN, CHES, FAAN, discusses the limitations of plastic-backed pads in inpatient oncology units.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
AnnMarie Walton, PhD, MPH, RN, OCN, CHES, FAAN, discusses the limitations of plastic-backed pads in inpatient oncology units.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
AnnMarie Walton, PhD, MPH, RN, OCN, CHES, FAAN, discusses the limitations of plastic-backed pads in inpatient oncology units.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Standardized Videos on the Double-Check Process Aims to Help Nurses Administer High-Alert Medications - 11 month(s) ago
Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, discusses how her institution improved double-check compliance with high-alert medications.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
📃 A research letter published in @EmergencyMedBMJ highlights how potentially harmful 'trip-killers' to cut short 'bad' drug trips after taking psychedelics is an emerging concern. 💊 #DrugSafety Read it here: https://t.co/dQbKMjy1xr https://t.co/ai8eebQjEq